RFPi, Inc Information

RFPi aspires to become a leader in real-time, non-invasive medical imaging. With two patents to date covering 66 claims providing comprehensive intellectual property protection, RFPi is commercializing proprietary blood-flow imaging devices that could: · Improve clinical outcomes for patients, lessening discomfort and stress. · Benefit surgeons by integrating views of physiologic circumstances during procedures in real time, without disrupting procedures or requiring patient contact. · Reduce costs for hospitals by reducing readmission rates for post-surgical complications. · Objectively measure outcomes, providing third-party payers with quantifiable performance data. RFPi’s working prototypes have been successfully deployed in three-plus years of pre-clinical and clinical studies. Earlier this year, RFPi submitted a 510(k) application with the U.S. Food and Drug Administration seeking approval for its first commercial product, the iCertainty platform for two-dimensional imaging of blood flow distribution (flow and perfusion) in tissues. RFPi’s technology was invented in 2010 at East Carolina University by a team of cardiovascular medicine, optical physics and engineering experts. Development has included bench-top and experimental studies, and clinical proof-of-concept and validation studies. This team continues to work closely with RFPi to commercialize these paradigm-changing medical imaging applications and devices. Videos demonstrating how RFPI’s iCertainty platform works can be seen on the company’s website at www.rfpi-co.com.